Overview

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Comparative pharmacokinetics of dipyridamole in two new formulations of Asasantin ER compared to the present commercial formulation
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Aspirin, Dipyridamole Drug Combination
Dipyridamole